Lilly focused on delivering the company’s unprecedented pipeline of next-generation medicines to help patients Amphastar is the ideal company to continue Lilly’s mission to help more people benefit…
Read More
On March 30th, 2022 the FDA released a Drug Safety Communication recommending monitoring of thyroid function in infants and children under 3 years of age within…
Read More
Great news regarding Pediatric Subspecialty Loan Repayment Program! One of the key recommendations of the PES Workforce Taskforce is to advocate for policies that lessen financial…
Read More
POSITION STATEMENT APRIL 2021 The Pediatric Endocrine Society Opposes Bills that Harm Transgender Youth Bills that threaten the health of transgender and gender diverse (TGD)…
Read More
Bills that threaten the health of transgender and gender diverse (TGD) youth have been introduced in multiple state legislatures across the United States. These bills undermine…
Read More
PES Leadership Advantage INSPIRE Module Registration is OPEN! PES Leadership Advantage provides physician leaders with the core skills key to becoming impactful voices at the leadership…
Read More
Early Bird Registration opens early March. Hold the dates now. DATES AND TIMES: Segment 1 Friday, May 21st, 2:00-4:30 ET Segment 2 Friday, June 4th, 2:00-4:30…
Read More
REGISTRATION IS OPEN!! We are so pleased to announce that the Registration Portal is now open for you to join us for the 2021 PES Virtual…
Read More
Fri 16 October 16, 2020 / 2:00 pm – 4:30 pm PES Leadership Advantage FALL MODULE OFFERING Since our virtual, live delivery of the INFLUENCE module…
Read More
PES Going Virtual for 2021 We are pleased to announce the dates for the PES 2021 VIRTUAL Annual Meeting! April 30th- May 3rd, 2021 We are…
Read More